The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

The Global Structural Heart Devices Market valued at $6.6 billion in 2021 is set to witness a growth rate of 10% in the next 5 years. The rising geriatric population & corresponding rise in the ...

A Fort Myers woman celebrated her 100th birthday at Health Park Medical Center, but the real highlight of her week was a successful heart valve repair. Zonda Montgomery woke up in her hospital ...

The nursing professor has been honored for significant contributions to cardiovascular and stroke research and clinical ...

The US Food and Drug Administration has approved Abbott's Tendyne Transcatheter Mitral Valve Replacement (TMVR) system. It is indicated for patients with mitral valve disease caused by ...